Changing the treatment paradigm for Parkinson’s disease psychosis with pimavanserin.

Changing the treatment paradigm for Parkinson’s disease psychosis with pimavanserin.
Related ArticlesChanging the treatment paradigm for Parkinson's disease psychosis with pimavanserin. Expert Rev Clin Pharmacol. 2019 Jun 04;: Authors: Lyons KE, Pahwa R, Hermanowicz N, Davis T, Pagan F, Isaacson S Abstract Introduction: Parkinson's disease psychosis (PDP) may affect up to 60% of patients with Parkinson's disease over the course of their disease, and is associated with poor prognosis, including ... read more
Source: PubMedPublished on 2019-06-05